QIAstat-Dx Syndromic Molecular Testing Versus Conventional Diagnostics in Acute Gastroenteritis: Impact on Pathogen...

Area of Science:

• Gastroenterology
• Clinical Diagnostics
• Molecular Biology

Background:

• Acute gastroenteritis presents a diagnostic challenge due to diverse and often overlapping etiologies.
• Conventional diagnostic methods like stool culture and antigen tests have limitations in pathogen coverage and sensitivity.
• Accurate laboratory support is crucial for identifying the cause of gastroenteritis.

Purpose of the Study:

• To evaluate the performance of the QIAstat-Dx Gastrointestinal Panel 2 for diagnosing acute gastroenteritis.
• To compare the molecular panel's diagnostic yield against traditional stool culture and antigen-based assays.
• To assess the clinical utility of a novel molecular diagnostic tool.

Main Methods:

• Analysis of 548 stool samples from patients with suspected gastroenteritis.
• Testing samples with the QIAstat-Dx Gastrointestinal Panel 2, stool culture, and rotavirus/adenovirus antigen tests.
• Comparison of pathogen detection rates and agreement between the molecular panel and conventional methods.

Main Results:

• The molecular panel detected pathogens in 50.4% of samples, significantly higher than stool culture (12.6%) and antigen assays (12.3% rotavirus, 4.4% adenovirus).
• Key pathogens identified included enteropathogenic Escherichia coli (15.3%), Campylobacter spp. (12.0%), and enteroaggregative E. coli (10.2%).
• Good agreement was observed for bacterial targets, while viral target agreement was lower, with discrepancies linked to antigen assay limitations.

Conclusions:

• The QIAstat-Dx Gastrointestinal Panel 2 enhances pathogen detection and provides rapid, comprehensive diagnostic information for gastroenteritis.
• Molecular diagnostics offer superior sensitivity and broader pathogen coverage compared to conventional methods.
• A combined approach utilizing molecular and conventional methods may optimize patient management strategies.